参考文献/References:
[1] AFZAAL M,SAEED F,SHAH Y A,et al.Human gut microbiota in health and disease:unveiling the relationship[J].Front Microbiol,2022,13:999001.
[2] ROGIER R,KOENDERS M I,ABDOLLAHI-ROODSAZ S.Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis[J].J Immunol Res,2015,2015:527696.
[3] 张海艇,张文.关节痛与关节炎的鉴别诊断[J].中华内科杂志,2015,54(6):538-540.
ZHANG H T,ZHANG W.Differential diagnosis of arthralgia and arthritis[J].Chin J Inter Med,2015,54(6):538-540.
[4] ZHAO T,WEI Y,ZHU Y,et al.Gut microbiota and rheumatoid arthritis:from pathogenesis to novel therapeutic opportunities[J].Front Immunol,2022,13:1007165.
[5] YANG K L,LEJEUNE A,CHANG G,et al.Microbial-derived antigens and metabolites in spondyloarthritis[J].Semin Immunopathol,2021,43(2):163-172.
[6] GLEASON B,CHISARI E,PARVIZI J.Osteoarthritis can also start in the gut:the gut-joint axis[J].Indian J Orthop,2022,56(7):1150-1155.
[7] QIN J,LI R,RAES J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59-65.
[8] MANICHANH C,BORRUEL N,CASELLAS F,et al.The gut microbiota in IBD[J].Nat Rev Gastroenterol Hepatol,2012,9(10):599-608.
[9] CLEMENTS S J,CARDING S R.Diet,the intestinal microbiota,and immune health in aging[J].Crit Rev Food Sci Nutr,2018,58(4):651-661.
[10] VAN DE WIELE T,VAN PRAET J T,MARZORATI M,et al.How the microbiota shapes rheumatic diseases[J].Nat Rev Rheumatol,2016,12(7):398-411.
[11] GEVA-ZATORSKY N,SEFIK E,KUA L,et al.Mining the human gut microbiota for immunomodulatory organisms[J].Cell,2017,168(5):928-943.
[12] GORKIEWICZ G,MOSCHEN A.Gut microbiome:a new player in gastrointestinal disease[J].Virchows Arch,2018,472(1):159-172.
[13] OPAZO M C,ORTEGA-ROCHA E M,CORONADO-ARRZOLA I,et al.Intestinal microbiota influences non-intestinal related autoimmune diseases[J].Front Microbiol,2018,9:432.
[14] TONG Y,MARION T,SCHETT G,et al.Microbiota and metabolites in rheumatic diseases[J].Autoimmun Rev,2020,19(8):102530.
[15] CHENG M,ZHAO Y,CUI Y,et al.Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis[J].Ann Rheum Dis,2022:annrheumdis-2022-222871.
[16] KALINKOVICH A,GABDULINA G,LIVSHITS G.Autoimmunity,inflammation,and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis[J].Immunol Res,2018,66(6):696-709.
[17] ZHANG X,ZHANG D,JIA H,et al.The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment[J].Nat Med,2015,21(8):895-905.
[18] CHEN J,WRIGHT K,DAVIS J M,et al.An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis[J]. Genome Med,2016,8(1):43.
[19] PIANTA A,ARVIKAR S,STRLE K,et al.Evidence of the immune relevance of prevotella copri,a gut microbe,in patients with rheumatoid arthritis[J].Arthritis Rheumatol,2017,69(5):964-975.
[20] MAEDA Y,KURAKAWA T,UMEMOTO E,et al.Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine[J].Arthritis Rheumatol,2016,68(11):2646-2661.
[21] PICKENS S R,CHAMBERLAIN N D,VOLIN M V,et al.Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization[J].Angiogenesis,2011,14(4):443-455.
[22] WU H J,IVANOV I I,DARCE J,et al.Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells[J].Immunity,2010,32(6):815-827.
[23] DULIC S,VSRHELYI Z,SAVA F,et al.T-cell subsets in rheumatoid arthritis patients on long-term anti-TNF or IL-6 receptor blocker therapy[J].Mediators Inflamm,2017,2017:6894374.
[24] JEONG Y,KIM J W,YOU H J,et al.Gut microbial composition and function are altered in patients with early rheumatoid arthritis[J].J Clin Med,2019,8(5):693.
[25] LPEZ-MEDINA C,MOLT A.Update on the epidemiology,risk factors,and disease outcomes of axial spondyloarthritis[J].Best Pract Res Clin Rheumatol,2018,32(2):241-253.
[26] RITCHLIN C T,COLBERT R A,GLADMAN D D.Psoriatic arthritis[J].N Engl J Med,2017,376(10):957-970.
[27] SCHER J U,UBEDA C,ARTACHO A,et al.Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis,resembling dysbiosis in inflammatory bowel disease[J].Arthritis Rheumatol,2015,67(1):128-139.
[28] RUUTU M,THOMAS G,STECK R,et al.β-glucan triggers spondylarthritis and Crohn′s disease-like ileitis in SKG mice[J].Arthritis Rheum,2012,64(7):2211-2222.
[29] BENHAM H,REHAUME L M,HASNAIN S Z,et al.Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice[J].Arthritis Rheumatol,2014,66(7):1755-1767.
[30] REHAUME L M,MONDOT S,AGUIRRE D C D,et al.ZAP-70 genotype disrupts the relationship between microbiota and host,leading to spondyloarthritis and ileitis in SKG mice[J].Arthritis Rheumatol,2014,66(10):2780-2792.
[31] GILIS E,MORTIER C,VENKEN K,et al.The role of the microbiome in gut and joint inflammation in psoriatic arthritis and spondyloarthritis[J].J Rheumatol Suppl,2018,94:36-39.
[32] TAUROG J D,RICHARDSON J A,CROFT J T,et al.The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats[J].J Exp Med,1994,180(6):2359-2364.
[33] LIN P,BACH M,ASQUITH M,et al.HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats[J].PLoS One,2014,9(8):e105684.
[34] WEN C,ZHENG Z,SHAO T,et al.Correction to:quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis[J].Genome Biol,2017,18(1):214.
[35] LI M,DAI B,TANG Y,et al.Altered bacterial-fungal interkingdom networks in the guts of ankylosing spondylitis patients[J].Systems,2019,4(2):e00176-18.
[36] YANG L,LIU B,ZHENG J,et al.Rifaximin alters intestinal microbiota and prevents progression of ankylosing spondylitis in mice[J].Front Cell Infect Microbiol,2019,9:44.
[37] MEASE P J,GLADMAN D D,PAPP K A,et al.Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics[J].J Am Acad Dermatol,2013,69(5):729-735.
[38] 雷元梅,王睿,郝震锋,等.寻常性银屑病亚临床关节炎的临床研究[J].实用皮肤病学杂志,2019,12(4):201-203.
LEI Y M,WANG R,HAO Z F.A clinical study of subclinical arthritis in patients with psoriasis vulgaris[J].J Pract Dermatol,2019,12(4):201-203.
[39] ARNOLD J W,ROACH J,FABELA S,et al.The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut[J].Microbiome,2021,9(1):31.
[40] HUO W,FENG Z,HU S,et al.Effects of polysaccharides from wild morels on immune response and gut microbiota composition in non-treated and cyclophosphamide-treated mice[J].Food Funct,2020,11(5):4291-4303.
[41] CORRA-OLIVEIRA R,FACHI J L,VIEIRA A,et al.Regulation of immune cell function by short-chain fatty acids[J].Clin Transl Immunology,2016,5(4):e73.
[42] TILLETT W,CHARLTON R,NIGHTINGALE A,et al.Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort[J].Rheumatology (Oxford),2017,56(12):2109-2113.
[43] LIVSHITS G,KALINKOVICH A.Hierarchical,imbalanced proi-nflammatory cytokine networks govern the pathogenesis of chronic arthropathies[J].Osteoarthritis Cartilage,2018,26(1):7-17.
[44] CANI P D,BIBILONI R,KNAUF C,et al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice[J].Diabetes,2008,57(6):1470-1481.
[45] HUANG Z Y,STABLER T,PEI F X,et al.Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation[J].Osteoarthritis Cartilage,2016,24(10):1769-1775.
[46] ULICI V,KELLEY K L,AZCARATE-PERIL M A,et al.Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice[J].Osteoarthritis Cartilage,2018,26(8):1098-1109.
[47] ZHAO L R,XING R L,WANG P M,et al.NLRP1 and NLRP3 inflammasomes mediate LPS/ATP-induced pyroptosis in knee osteoarthritis[J].Mol Med Rep,2018,17(4):5463-5469.
[48] CLARKE S F,MURPHY E F,O′SULLIVAN O,et al.Targeting the microbiota to address diet-induced obesity:a time dependent challenge[J].PLoS One,2013,8(6):e65790.
[49] SCHOTT E M,FARNSWORTH C W,GRIER A,et al.Targeting the gut microbiome to treat the osteoarthritis of obesity[J].JCI Insight,2018,3(8):e95997.
相似文献/References:
[1]张永辉,宋伟涛,刘宗花,等.中药泡桐花浸膏防治支气管哮喘的实验性研究[J].新乡医学院学报,2002,19(03):186.
[2]晋乐飞1,冯斐斐1,吴卫东. 大气细颗粒污染物对呼吸系统危害研究进展 [J].新乡医学院学报,2015,32(02):091.[doi:10.7683/xxyxyxb.2015.02.001]
[3]李 航,郭伟丽,安 珍,等.PM2.5对慢性阻塞性肺疾病影响研究进展[J].新乡医学院学报,2016,33(3):234.[doi:10.7683/xxyxyxb.2016.03.020]
LI Hang,GUO Weili,AN Zhen,et al.Research progress on the effect of PM2.5 on chronic obstructive pulmonary disease[J].Journal of Xinxiang Medical University,2016,33(11):234.[doi:10.7683/xxyxyxb.2016.03.020]
[4]马斐斐,曹丁丁,李 伟,等.趋化因子CXCL1在肥胖小鼠脂肪组织中的表达及意义[J].新乡医学院学报,2016,33(10):849.[doi:10.7683/xxyxyxb.2016.10.003]
MA Fei-fei,CAO Ding-ding,LI Wei,et al.Expression and significance of chemokine CXCL1 in the adipose tissue of mice with obesity[J].Journal of Xinxiang Medical University,2016,33(11):849.[doi:10.7683/xxyxyxb.2016.10.003]
[5]姜晓旭,李明哲,赵九洲,等.巨噬细胞在肥胖进程中的作用研究进展[J].新乡医学院学报,2019,36(7):694.[doi:10.7683/xxyxyxb.2019.07.024]
[6]阎婷婷,赵英政,易宪文,等.氧化应激及炎症对糖尿病肾病的影响[J].新乡医学院学报,2019,36(8):701.[doi:10.7683/xxyxyxb.2019.08.001]
[7]房新辉,李 健.血必净注射液对慢加急性肝衰竭合并自发性腹膜炎患者凝血功能和肝功能及炎性因子水平的影响[J].新乡医学院学报,2018,35(11):997.[doi:10.7683/xxyxyxb.2018.11.013]
FANG Xin-hui,LI Jian.Effect of Xuebijing injection on coagulation function,liver function and inflammatory factor level of patients with acute-on-chronic liver failure complicated with spontaneous bacterial peritonitis[J].Journal of Xinxiang Medical University,2018,35(11):997.[doi:10.7683/xxyxyxb.2018.11.013]
[8]郭依宁,于忠杨,冷锦红.卫星胶质细胞对痛性糖尿病周围神经病变影响的研究进展[J].新乡医学院学报,2018,35(11):1039.[doi:10.7683/xxyxyxb.2018.11.024]
N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(11):1039.[doi:10.7683/xxyxyxb.2018.11.024]
[9]王荣荣,张子璐,李嘉欣,等.酒精所致氧化应激相关研究进展[J].新乡医学院学报,2019,36(9):891.[doi:10.7683/xxyxyxb.2019.09.021]
[10]庞红利,宋俊杰,范军朝,等.七氟醚后处理对脑缺血再灌注损伤大鼠的保护作用及对Toll样受体4/核因子-κB信号通路的影响[J].新乡医学院学报,2020,37(1):021.[doi:10.7683/xxyxyxb.2020.01.006]
PANG Hongli,SONG Junjie,FAN Junchao,et al.Protective effect of sevoflurane post-conditioning on cerebral ischemia-reperfusion injury rats and its effect on toll-like receptor 4/nuclear factor-κB signaling pathway[J].Journal of Xinxiang Medical University,2020,37(11):021.[doi:10.7683/xxyxyxb.2020.01.006]